Skip to main content
SpringerLink
Log in

Metabolic Changes at the Menopausal Transition

  • Chapter
  • First Online:
Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health

Part of the book series: ISGE Series ((ISGE))

  • 527 Accesses

Abstract

Obesity and its related severe consequences have been a major public health problem worldwide. A significant weight gain and intra-abdominal adipose tissue accumulation are observed as women begin the menopausal transition. Nowadays, the change of body weight during menopausal transition represents an important topic of discussion. A number of clinical and basic research indicate that ovarian hormone may play a crucial role. How do hormonal changes in menopause lead to alterations in lipid and glucose metabolism, fat distribution, and food intake? Understanding the ovarian hormones’ influences on lipid and glucose metabolism, and on the regulation of body weight could be an attractive target. A variety of research modalities have been used to explore the effects of MHT on body mass, body fat redistribution, and insulin resistance in perimenopausal women, which lead to protective cardiometabolic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow SD, Skurnick J. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol. 2001;153(9):865–74.

    Article  CAS  PubMed  Google Scholar 

  2. Dratva J, Gómez Real F, Schindler C, Ackermann-Liebrich U, Gerbase MW, Probst-Hensch NM, Svanes C, Omenaas ER, Neukirch F, Wjst M, Morabia A, Jarvis D, Leynaert B, Zemp E. Is age at menopause increasing across Europe? Results on age at menopause and determinants from two population-based studies. Menopause. 2009;16(2):385–94.

    Article  PubMed  Google Scholar 

  3. Kriplani A, Banerjee K. An overview of age of onset of menopause in northern India. Maturitas. 2005;52(3–4):199–204.

    Article  PubMed  Google Scholar 

  4. Lobo RA, Davis SR, De Villiers TJ, Gompel A, Henderson VW, Hodis HN, Lumsden MA, Mack WJ, Shapiro S, Baber RJ. Prevention of diseases after menopause. Climacteric. 2014;17(5):540–56.

    Article  CAS  PubMed  Google Scholar 

  5. Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, Beresford SA, Cauley JA, Eaton CB, Gass M, Hsia J, Johnson KC, Kooperberg C, Kuller LH, Lewis CE, Liu S, Martin LW, Ockene JK, O’Sullivan MJ, Powell LH, Simon MS, Van Horn L, Vitolins MZ, Wallace RB. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353–68.

    Google Scholar 

  6. Wellons M, Ouyang P, Schreiner PJ, Herrington DM, Vaidya D. Early menopause predicts future coronary heart disease and stroke: the multi-ethnic study of atherosclerosis. Menopause. 2012;19(10):1081–7.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41.

    Article  CAS  PubMed  Google Scholar 

  8. Genazzani AD, Vito G, Lanzoni C, Strucchi C, Mehmeti H, Ricchieri F, Mbusnum MN. La Sindrome Metabolica menopausale. Giorn It Ost Gin. 2005;11(12):487–93.

    Google Scholar 

  9. Ibrahim M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11–8.

    Article  PubMed  Google Scholar 

  10. Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM. International day for the evaluation of abdominal obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation. 2007;116(17):1942–51.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET. Menopause-related differences in in ammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril. 2002;77:128–35.

    Article  PubMed  Google Scholar 

  12. Genazzani AD, Prati A, Despini G. Metabolic changes and metabolic syndrome during the menopausal transition. In: Birkhaeuser M, Genazzani A, editors. Pre-menopause, menopause and beyond. Cham: ISGE Series. Springer; 2018.

    Google Scholar 

  13. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P. Writing Group of the International Menopause Society for World Menopause Day 2012. Understanding weight gain at menopause. Climacteric. 2012;15(5):419–29.

    Article  CAS  PubMed  Google Scholar 

  14. Lovejoy JC, Champagne CM, De Longe L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32(6):949–58.

    Article  CAS  Google Scholar 

  15. Cagnacci A, Volpe A, Paoletti AM, Melis GB. Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. Fertil Steril. 1997;68(3):421.

    Article  CAS  PubMed  Google Scholar 

  16. Webb P. 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr. 1986;44:14.

    Article  Google Scholar 

  17. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, DeSimone L, Genazzani AR. Climacteric modifications in body weight and fat tissue distribution. Climateric. 1999;2(1):37–44.

    Article  CAS  Google Scholar 

  18. Roubenoff R, Hughes VA, Dallal GE, Nelson ME, Morganti C, Kehayias JJ, Singh MA, Roberts S. The effect of gender and body composition method on the apparent decline in lean mass-adjusted resting metabolic rate with age. J Gerontol A Biol Sci Med Sci. 2000;55(12):M757–60.

    Article  CAS  PubMed  Google Scholar 

  19. Ravussin E, Lillioja S, Knowler WC, Christin L, Freymond D, Abbott WG, Boyce V, Howard BV, Bogardus C. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med. 1988;318(8):467–72.

    Article  CAS  PubMed  Google Scholar 

  20. Veldhuis JD, Bowers CY. Sex-steroid modulation of growth hormone (GH) secretory control: three-peptide ensemble regulation under dual feedback restraint by GH and IGF- I. Endocrine. 2003;22(1):25–40.

    Article  CAS  PubMed  Google Scholar 

  21. Walenkamp JD, Wit JM. Genetic disorders in the growth hormone-insulin-like growth factor-I axis. Horm Res. 2006;66(5):221–30.

    CAS  PubMed  Google Scholar 

  22. Peppa M, Koliacki C, Dimitriadis G. Body composition as an important determinant of metabolic syndrome in postmenopausal women. Endocrinol Metabol Syndr. 2012;2:1.

    Article  Google Scholar 

  23. Messina G, Viggiano A, DeLuca V, Messina A, Chief S, Monda M. Hormonal changes in menopause and orexin-a action. Obst Gynecol Int. 2013;2013:1–5.

    Article  CAS  Google Scholar 

  24. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Ann Rev Neurosci. 2001;24:429–58.

    Article  CAS  PubMed  Google Scholar 

  25. Kukkonen JP, Holmqvist T, Ammoun S, Akerman KEO. Functions of the orexinergic/hypocretinergic system. Am J Phys. 2002;283(6):C1567–91.

    Article  CAS  Google Scholar 

  26. El-Sedeek M, Korish AA, Deef MM. Plasma orexin-a levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status. BJOG. 2010;117(4):488–92.

    Article  CAS  PubMed  Google Scholar 

  27. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: the study of Women's health across the nation. Am J Epidemiol. 2009;169(11):1352–61.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Carr MC, Kim KH, Zambon A, Mitchell ES, Woods NF, Casazza CP, Purnell JQ, Hokanson JE, Brunzell JD, Schwartz RS. Changes in LDL density across the menopausal transition. J Investig Med. 2000;48(4):245–50.

    CAS  PubMed  Google Scholar 

  29. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. El Khoudary SR. HDL and the menopause. Curr Opin Lipidol. 2017;28(4):328–36.

    Article  PubMed  CAS  Google Scholar 

  31. Chen L, Wu M, Zhang S, Tan W, Guan M, Feng L, Chen C, Tao J, Chen L, Qu L. Estrogen-related receptor γ regulates hepatic triglyceride metabolism through phospholipase A2 G12B. FASEB J. 2019;33(7):7942–52.

    Article  CAS  PubMed  Google Scholar 

  32. Pulchinelli A Jr, Costa AM, de Carvalho CV, de Souza NC, Haidar MA, Andriolo A, da Silva ID. Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response. Lipids Health Dis. 2011;10:197.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ghosh M, Gälman C, Rudling M, Angelin B. Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol. J Lipid Res. 2015;56(2):463–9. https://doi.org/10.1194/jlr.M055780. Epub 2014 Dec 22. Erratum in: J Lipid Res. 2018;59(11):2253.

  34. Persson L, Henriksson P, Westerlund E, Hovatta O, Angelin B, Rudling M. Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women. Arterioscler Thromb Vasc Biol. 2012;32(3):810–4.

    Article  CAS  PubMed  Google Scholar 

  35. Baber RJ, Panay N. Fenton a; IMS writing group. 2016 IMS recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–50.

    Article  CAS  PubMed  Google Scholar 

  36. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril. 2001;75(5):898–915.

    Article  CAS  PubMed  Google Scholar 

  37. Stevens VL, Wang Y, Carter BD, Gaudet MM, Gapstur SM. Serum metabolomic profiles associated with postmenopausal hormone use. Metabolomics. 2018;14(7):97.

    Article  PubMed  CAS  Google Scholar 

  38. Genazzani AD, Ricchieri F, Lanzoni C. Use of metformin in the treatment of polycystic ovary syndrome. Womens Health. 2010;6(4):577–93.

    CAS  Google Scholar 

  39. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol. 2000;142(3):269–73.

    Article  CAS  PubMed  Google Scholar 

  40. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril. 2009;91:207–12.

    Article  PubMed  Google Scholar 

  41. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008;24(3):139–44.

    Article  CAS  PubMed  Google Scholar 

  42. Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, Tapanainen JS. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab. 2011;96(6):1827–34.

    Article  CAS  PubMed  Google Scholar 

  43. Roussel M, Garnier S, Lemoine S, Gaubert I, Charbonnier L, Auneau G, Mauriège P. Influence of a walking program on the metabolic risk pro le of obese postmenopausal women. Menopause. 2009;16(3):566–75.

    Article  PubMed  Google Scholar 

  44. Martins C, Kulseng B, King NA, Holst JJ, Blundell JE. The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J Clin Endocrinol Metab. 2010;95:1609–16.

    Article  CAS  PubMed  Google Scholar 

  45. Genazzani AR, Gambacciani M. Effect of climacteric transition and hormone replace- ment therapy on body weight and body fat distribution. Gynecol Endocrinol. 2006;22(3):145–50.

    Article  CAS  PubMed  Google Scholar 

  46. Tommaselli GA, DiCarlo C, Di Spiezio SA, Bifulco CG, Cirillo D, Guida M, Papasso R, Nappi C. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause. 2006;13:660–8.

    Article  PubMed  Google Scholar 

  47. Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C. Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause. 2004;11:466–73.

    Article  PubMed  Google Scholar 

  48. dos Reis CM, de Melo NR, Meirelles ES, Vezozzo DP, Halpern A. Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas. 2003;46:59–68.

    Article  PubMed  CAS  Google Scholar 

  49. Morris DH, Jones ME, Schoemaker MJ, McFadden E, Ashworth A, Swerdlow AJ. Body mass index, exercise, and other lifestyle factors in relation to age at natural menopause: analyses from the breakthrough generations study. Am J Epidemiol. 2012;175:998–1005.

    Article  PubMed  Google Scholar 

  50. Krents AJ, von Muhlen D, Barret-Connor E. Adipocytokine pro les in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the rancho Bernardo study. Metabolism. 2012;61:1238–41.

    Article  CAS  Google Scholar 

  51. Douketis JD, Macie C, Thabane L, Williamson DF. Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes. 2005;29:1153–67.

    Article  CAS  Google Scholar 

  52. Freedman MR, King J, Kennedy E. Popular diets: a scientific review. Obes Rev. 2001;9(Suppl 1):1–40S.

    Google Scholar 

  53. Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia. Gynecol Endocrinol. 2007;23:146–52.

    Article  CAS  PubMed  Google Scholar 

  54. Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, Kaaja R, Mikkola T, Palacios S, Preston R, Simon T, Stevenson J, Stramba-Badiale M. Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric. 2007;10(6):508–26.

    Article  CAS  PubMed  Google Scholar 

  55. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–90.

    Article  CAS  PubMed  Google Scholar 

  56. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, lung, and BloodInstitute/ American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.

    Article  PubMed  Google Scholar 

  57. Hodis HN, Mack WJ. The timing hypothesis: a paradigm shift in the primary prevention of coronary heart disease in women: part 1, comparison of therapeutic efficacy. J Am Geriatr Soc. 2013;61(6):1005–10.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Conflicts of Interest

No conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

    Marta Caretto, Andrea Giannini, Giulia Palla & Tommaso Simoncini

Authors
  1. Marta Caretto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Giannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giulia Palla
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tommaso Simoncini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tommaso Simoncini .

Editor information

Editors and Affiliations

  1. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

  2. Endocrinology Department, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain

    Lourdes Ibáñez

  3. Department of Endocrinology, Diabetology, Wrocław Medical University, Wroclaw, Poland

    Andrzej Milewicz

  4. Obstetrics and Gynecology, Gynaecworld, Mumbai, India

    Duru Shah

Rights and permissions

Reprints and permissions

Copyright information

© 2021 International Society of Gynecological Endocrinology

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Caretto, M., Giannini, A., Palla, G., Simoncini, T. (2021). Metabolic Changes at the Menopausal Transition. In: Genazzani, A.R., Ibáñez, L., Milewicz, A., Shah, D. (eds) Impact of Polycystic Ovary, Metabolic Syndrome and Obesity on Women Health. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-63650-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-63650-0_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-63649-4

  • Online ISBN: 978-3-030-63650-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation